Objective:

To provide a comprehensive listing of active interventional clinical trials related to various types of glaucoma.

Key Findings:

• Multiple trials are focused on assessing the safety and efficacy of new treatments for glaucoma, including drug therapies and surgical interventions.
• Trials include various approaches such as drug therapies, surgical interventions, and innovative delivery methods, with specific examples provided.
• Enrollment sizes vary across studies, indicating a range of participant involvement, which may affect the generalizability of results.

Interpretation:

The ongoing clinical trials reflect a diverse range of therapeutic strategies aimed at improving outcomes for patients with glaucoma.

Limitations:

• The article does not provide detailed results or outcomes from the listed trials, which limits understanding of their impact.
• No information on the geographical distribution of the trials is included, which may affect the applicability of findings to different populations.

Conclusion:

The tracker serves as a valuable resource for healthcare professionals and researchers interested in the latest developments in glaucoma treatment, highlighting the ongoing research landscape.